Search clinical trials for: CT-P17 SC AI (adalimumab)

Total 284 results

Celltrion
PPD

Completed

A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P17 in Patients With Active Rheumatoid Arthritis

Rheumatoid Arthritis

Poland
Celltrion

Completed

A Study to Compare Efficacy and Safety of CT-P17 With Humira in Patients With Active Rheumatoid Arthritis

Rheumatoid Arthritis

Bulgaria
Celltrion

Not yet recruiting

A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P47 in Patients With Active Rheumatoid Arthritis

Rheumatoid Arthritis
Centre for Human Drug Research, Netherlands
Leiden University Medical Center; Leiden Academic Center for Drug Research,...

Completed

Adalimumab Microneedles in Healthy Volunteers

Pain | Injection Site

Netherlands
Celltrion

Recruiting

To Compare Pharmacokinetics, Efficacy, and Safety of CT-P17 With Humira in Patients With Moderate to Severe Chronic Plaque Psoriasis

Moderate to Severe Chronic Plaque Psoriasis

Estonia
Celltrion

Completed

CT-P13 (Infliximab) Subcutaneous Administration by Pre-filled Syringe and Auto-injector in Healthy Subjects

Health, Subjective

United States
Celltrion

Completed

To Compare the Pharmacokinetics and Safety of CT-P17 and Humira in Healthy Subjects

Healthy

Korea, Republic of
Celltrion

Completed

To Compare the Pharmacokinetics and Safety of the Auto-injector and Pre-filled Syringe of CT-P17

Healthy

United States
Celltrion

Completed

CT-P13 (Infliximab) Subcutaneous Administration in Patients With Moderately to Severely Active Crohn's Disease (LIBERTY-CD)

Crohn's Disease

France, Turkey, Czechia, Greece, Latvia, Hungary, Belarus, Israel, United States, Spain, Bulgaria, Serbia, Croatia, Italy, Germany, India, Japan, Mexico, Moldova, Republic of, Peru, Poland, Romania, Russian Federation, Slovakia, South Africa and more
Celltrion

Completed

CT-P13 (Infliximab) Subcutaneous Administration in Patients With Moderately to Severely Active Ulcerative Colitis (LIBERTY-UC)

Ulcerative Colitis

Poland
Charite University, Berlin, Germany
Abbott

Unknown

D2E7-Early AS

Ankylosing Spondylitis

Germany
argenx

Completed

SAD and MAD Study With IV and SC Doses of ARGX-117 (ARGX-117)

Healthy Volunteers

Netherlands
Abbott

Completed

A Long Term Roll-over Study to Investigate the Efficacy and Safety of Adalimumab Given Long-term to Patients With Rheumatoid Arthritis

Rheumatoid Arthritis
University Hospital, Ghent

Completed

Study to Evaluate the Efficacy of Adalimumab in Patients With Erosive Osteoarthritis of the Interphalangeal Finger Joints

Erosive Osteo-Arthritis

Belgium
Carmot Therapeutics, Inc.

Completed

A Study to Assess CT-868 and the Relationship Between Insulin Secretory Response and Ambient Blood Glucose.

Diabetes

United States
Celltrion

Terminated

A Study to Evaluate the Efficacy and Safety of CT-P27 in Acute Uncomplicated Influenza A Infection

Influenza A

Korea, Republic of
Zuyderland Medisch Centrum

Enrolling by invitation

Switching From Intravenous to Subcutaneous Infliximab in Adult Patients With Inflammatory Bowel Disease (SHUFFLE)

Crohn Disease | Ulcerative Colitis | IBD | Infliximab

Netherlands
Janssen Research & Development, LLC
GlaxoSmithKline

Completed

Bioavailability and Pharmacokinetics Study of Sirukumab in Healthy Male Participants

Healthy

United States
Celltrion

Recruiting

Compare the Auto-injector and Pre-filled Syringe of CT-P47 in Healthy Subjects

Healthy Subjects

Korea, Republic of
Celltrion

Completed

A Study to Evaluate the Efficacy and Safety of CT-P27 in an Influenza Challenge Model

Influenza A

United Kingdom
Elin Tragardh
Lund University

Recruiting

AI-based Measurements of Tumour Burden in PSMA PET-CT

Prostate Cancer

Sweden
Groupe d'Etude Therapeutique des Affections Inflammatoires...
Celltrion

Active, not recruiting

A 24-month Real Life PErsistence Efficacy and Safety Study in IBD Patients in REMission Switched From Intravenous Infliximab to Subcutaneous Infliximab CT-P13 Remsima®SC (PEREM)

Inflammatory Bowel Diseases

France
Celltrion

Recruiting

A Study to Compare the Pharmacokinetics and Safety of CT-P47 and RoActemra in Healthy Subjects

Healthy Subjects

Korea, Republic of
University of Roma La Sapienza
Federico II University; University of Padova

Not yet recruiting

Total Small Bowel Length Measurement Using Computed Tomography and Magnetic Resonance Imaging in Obese Patients (SBOM-AI)

Obesity | Bariatric Surgery Candidate
First Affiliated Hospital Xi'an Jiaotong University

Recruiting

99mTc-P137 SPECT/CT in Prostate Cancer

Prostate Cancer

China
University of Helsinki
AbbVie

Unknown

Adalimumab in Alleviating Inflammation in Patients With Axial Spondyloarthritis (PETSPA)

Ankylosing Spondyloarthritis

Finland
City of Hope Medical Center
National Cancer Institute (NCI)

Recruiting

Multiple Doses of Neural Stem Cell Virotherapy (NSC-CRAd-S-pk7) for the Treatment of Recurrent High-Grade Gliomas

Recurrent Glioblastoma | Recurrent Malignant Glioma | Recurrent WHO Grade III Glioma | Recurrent WHO Grade II Glioma | Recurrent Gliosarcoma | Recurrent Anaplastic Astrocytoma | Recurrent Anaplastic Oligoastrocytoma | Recurrent Anaplastic Oligodendroglioma

United States
IRCCS San Raffaele

Recruiting

EFFICACY AND SAFETY OF S.C. INFLIXIMAB IN PATIENTS SWITCHED FROM I.V. FORMULATION OF INFLIXIMAB

Inflammatory Bowel Diseases | Rheumatologic Disease

Italy
Five Eleven Pharma, Inc.
Indiana University

Active, not recruiting

Biodistribution and Dosimetry of Ga-68 P16-093 in Prostate Cancer

Prostate Cancer | Prostate Cancer Recurrent

United States
Celltrion

Completed

A Phase I Study to Evaluate Pharmacokinetics, Efficacy and Safety of CT-P13 Subcutaneous in Patients With Active Crohn's Disease and Ulcerative Colitis

Crohn's Disease | Ulcerative Colitis (Part 2 Only)

Korea, Republic of
Celltrion

Completed

A Phase I/III Study to Evaluate Efficacy, PK and Safety Between CT-P13 SC and CT-P13 IV in Patients With Active RA

Rheumatoid Arthritis

Korea, Republic of
University Hospital, Bordeaux

Recruiting

68Ga-RM2 Compared to 68Ga-PSMA-617 PET/CT for Intermediate Risk Prostate Cancer Imaging (PROSTATEP)

Prostate Cancer

France
CMC Ambroise Paré
Celltrion HealthCare France; Paris IBD Center

Not yet recruiting

Pharmacokinetics, Efficacy and Safety of CT-P13 Subcutaneous as Induction Therapy in Patients With Active CD or UC (PASSPORT)

Inflammatory Bowel Diseases
Celltrion
Pfizer

Completed

Demonstrate Noninferiority in Efficacy and to Assess Safety of CT-P13 in Patients With Active Crohn's Disease

Crohn's Disease

United States
University Hospital, Bordeaux

Completed

68Ga-RM2 Compared to 68Ga-PSMA-617 PET/CT for Prostate Cancer Imaging According to Various Metastatic Risks (UROPET)

Prostate Cancer

France
Pfizer
Hospira, now a wholly owned subsidiary of Pfizer

Completed

Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Rheumatoid Diseases Who Are Naïve To Biologics Or Switched From Remicade (PERSIST)

Rheumatoid Arthritis | Psoriatic Arthritis | Ankylosing Spondylitis | Rheumatoid Diseases

Spain, Canada, Greece, United Kingdom, Germany, Bulgaria, Czechia
Pfizer
Hospira, now a wholly owned subsidiary of Pfizer

Completed

Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Inflammatory Bowel Disease (CONNECT-IBD)

Inflammatory Bowel Diseases | Crohn's Disease | Ulcerative Colitis

France, Spain, United Kingdom, Czechia, Italy, Belgium, Germany, Netherlands, Greece, Finland, Hungary, Portugal, Slovakia
Asan Medical Center

Not yet recruiting

TDM-based Infliximab Treatment for Active Perianal Fistulizing Crohn's Disease

Crohn Disease | Therapeutic Drug Monitoring | Infliximab | Perianal Fistula Due to Crohn's Disease | Magnetic Resonance Novel Index for Fistula Imaging in Crohn's Disease Score
Celltrion

Not yet recruiting

A Study to Compare Efficacy and Safety of CT-P47 and RoActemra in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis
Steve N. Caritis, MD
AMAG Pharmaceuticals, Inc.

Terminated

17-OHPC in Pregnancy: IM vs SC Routes

Preterm Birth

United States
Celltrion

Completed

To Compare Efficacy and Safety Between CT-P10 and Rituxan in Patients With Low Tumour Burden Follicular Lymphoma

Follicular Lymphoma

Korea, Republic of
Celltrion

Completed

PK Similarity Prospective Phase 3 Study in Patients With Rheumatoid Arthritis (rituximab)

Rheumatoid Arthritis
Celltrion

Completed

To Compare the Efficacy, Pharmacokinetics and Safety Between CT-P13 and China Approved Remicade When Co-administered With Methotrexate in Patients With Active Rheumatoid Arthritis

Rheumatoid Arthritis

China
University of Calgary
Alimentiv Inc.

Recruiting

PATHFINDER: Evaluating the Optimal First-Line Treatment Strategy for Moderate-to-Severely Active Ileal-dominant Crohn's Disease

Crohn Disease

Canada
Cedars-Sinai Medical Center
Astellas Pharma US, Inc.

Completed

Adenosine Dual Source Computed Tomography (CT) Versus Adenosine Single Photon Emission Computed Tomography (SPECT)

Coronary Artery Disease

United States
Minneamrita Therapeutics LLC

Recruiting

Minnelide Along With Abraxane Plus Gemcitabine in Patients With Metastatic Adenocarcinoma of the Pancreas

Metastatic Adenocarcinoma of the Pancreas

Korea, Republic of
Emory University
Siemens Medical Solutions

Recruiting

The MATCH Investigation: CT Myocardial Perfusion and CT-FFR vs PET MPI

Coronary Artery Disease

United States
Celltrion

Completed

To Demonstrate Similarity of Pharmacokinetics and Evaluate Safety of CT-P16, EU-Approved Avastin and US-licensed Avastin

Healthy

Korea, Republic of
Celltrion

Completed

Long-Term Efficacy and Safety of CT-P10 in Patients With RA

Rheumatoid Arthritis

Korea, Republic of
National Cancer Institute (NCI)
NRG Oncology

Recruiting

Testing the Addition of the AKT Inhibitor, Ipatasertib, to Treatment With the Hormonal Agent Megestrol Acetate for Recurrent or Metastatic Endometrial Cancers

Recurrent Endometrial Endometrioid Adenocarcinoma | Stage IV Uterine Corpus Cancer AJCC v8 | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma | Metastatic Endometrial Endometrioid Adenocarcinoma

United States

Search clinical trials for: CT-P17 SC AI (adalimumab)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mozambique

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations